AZD4547 is a novel selective FGFR inhibitor targeting FGFR1/2/3 with IC50 of 0.2 nM/2.5 nM/1.8 nM, weaker activity against FGFR4, VEGFR2(KDR), and little activity observed against IGFR, CDK2, and p38. Phase 2/3.A novel selective FGFR inhibitor targeting FGFR1, FGFR2, and FGFR3.
Specifications and Purity: ≥99%
Molecular Formula: C26H33N5O3
Molecular Weight: 463.57
PubChem CID: 51039095
Isomeric SMILES: C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/A127209-SCI_021e02677c06660f8824c87deae1b3bf.pdf
- UPC:
- 12352125
- Condition:
- New
- HazmatClass:
- Yes
- WeightUOM:
- LB
- MPN:
- A127209-10mg
- CAS:
- 1035270-39-3
- Health Hazards:
- Toxic
- Product Size:
- 10mg
- Hazard Statement Codes:
- H302:H301
- Precautionary Statement Codes:
- P501:P405:P301+P312:P330:P270:P264:P260
akash.verma@cenmed.com
(732) 447-1115





